Something’s going to give, and soon. That’s the forecast from many cannabis industry observers for federal marijuana reform. The real question is how.
Omar Sacirbey
Omar Sacirbey's Latest Posts
Pros and cons of moving marijuana from Schedule 1 on the list of controlled substances
The absurdity of federal marijuana policy in the United States is perhaps best symbolized by the placement of cannabis on Schedule 1 of the Controlled Substances Act, according to industry observers.
NFL’s changing perception of marijuana sharing center stage with Super Bowl
Marijuana has become part of the hype and hoopla running up to Sunday’s Super Bowl.
But it’s not because the league suspended any players for failing or missing testing for such banned substances as marijuana, as it has in past seasons with star players such as Josh Gordon, Von Miller and Santonio Holmes.
Delta-8 Debate: The 2018 Farm Bill gave rise to an unlikely intoxicant
The 2018 U.S. Farm Bill unleashed large supplies of CBD distillate, which can be turned into a rare, intoxicating cannabinoid: delta-8 THC.
Is delta-8 THC a threat to the marijuana industry?
Delta-8 THC has been most popular in states where traditional delta-9 cannabis is prohibited or highly restricted, a difference experts attribute to availability and access.
Scientists believe bioreactors could augment cannabis agriculture
BioHarvest Sciences, a company that biosynthetically created grape and pomegranate extracts to sell to food ingredient companies and consumers, claims to have done the same with cannabis.
The Controlled Substances Act leaves pathway for intoxicating hemp-derived cannabinoids
Delta-8 THC exploded onto the scene in 2019, followed by delta-10 THC, THC-O acetate and HHC in 2020 and 2021.
While state regulatory agencies have opted for a whack-a-mole approach that focuses on controlling one cannabinoid at a time, the federal government has been largely silent on the legal status of hemp-derived cannabinoids.
‘Consumable’ hemp paves way for Louisiana’s D-8 THC experiment
While many states responded to the delta-8 THC phenomenon by banning the cannabinoid, other markets sought to tame it by regulating D-8 products, mandating testing and enforcing other compliance standards.
In Louisiana, regulators and stakeholders hope this approach will reduce safety hazards and clear up confusion over which cannabinoid products can and can’t be sold in the state.
Widespread crackdown on delta-8 THC could pose a threat to other cannabinoids
Delta-8’s meteoric rise in popularity is forcing a conversation about how to regulate minor cannabinoids.
Until recently, delta-8 THC has existed in an unregulated, legal gray area. And because there are dozens of other minor cannabinoids not covered by federal and state laws, regulating D-8 could have wider ramifications.
Illinois marijuana workers for PharmaCann, Curaleaf vote to unionize
Employees at two retail marijuana operations owned by PharmaCann in the Chicago area and at Curaleaf Holdings’ store in Mokena, Illinois, are joining labor unions.
Cannabis education, demographics and product familiarity all help win over buyers
The marijuana industry has never been so replete with cannabis product formats: flower, vape cartridges, concentrates, edibles and infused beverages as well as topicals, tinctures, capsules and other offerings.
Older legal markets report increased interest in edibles and vapes, but passion for flower remains
Marijuana businesses in new markets can expect consumer knowledge and tastes to change over time, but not by much. According to retailers in mature recreational marijuana markets, flower remains the most popular product format.
